Eyecirque Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 24-10-2024
- Paid Up Capital ₹ 0.50 M
as on 24-10-2024
- Company Age 43 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit -18.62%
(FY 2023)
- Ebitda -18.62%
(FY 2023)
- Net Worth -49.26%
(FY 2023)
- Total Assets -38.32%
(FY 2023)
About Eyecirque
The Corporate was formerly known as Vision Pharmaceuticals Pvt Ltd. The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Kishore Masurkar, Rita Masurkar, and Nikhil Masurkar serve as directors at the Company.
- CIN/LLPIN
U24230MH1981PTC025750
- Company No.
025750
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Dec 1981
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Eyecirque?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nikhil Masurkar  | Director | 01-Apr-2012 | Current |
| Kishore Masurkar | Director | 01-Apr-2009 | Current |
| Rita Masurkar | Director | 01-Apr-2009 | Current |
Financial Performance of Eyecirque.
Eyecirque Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 18.62% decrease in profit. The company's net worth observed a substantial decline by a decrease of 49.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eyecirque?
In 2023, Eyecirque had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Entod Pharmaceuticals LimitedActive 43 years 2 monthsKishore Masurkar, Rita Masurkar and 1 more are mutual person
- Entod Healthcare Private LimitedActive 20 years 1 day
Kishore Masurkar, Rita Masurkar and 1 more are mutual person
- Medisearch Laboratories (Bombay) Private LimitedActive 39 years 2 months
Kishore Masurkar is a mutual person
- Matanand Welfare FoundationActive 10 months 23 days
Kishore Masurkar, Rita Masurkar and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eyecirque?
Unlock and access historical data on people associated with Eyecirque, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eyecirque, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eyecirque's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
